Neurological disorders Huntington disease Huntington's disease (HD) is a neurodegenerative disorder that involves alterations in neuronal pathways. The inhibitory-to-excitatory shift in GABAergic transmission is an important change, which is largely related to the disruption of chloride
homeostasis. The NKCC1 inhibitor
bumetanide helps to lower the intracellular chloride levels and restores inhibitory GABAergic signaling. In Huntington’s disease mouse models, treatment with
bumetanide successfully restored GABAergic inhibition and improved hippocampal-dependent learning and memory.
Down syndrome Down syndrome is a genetic disorder characterized by altered hippocampal-related functions, including deficits in memory, learning, and cognitive ability. In the Down syndrome mouse model that replicated the main features of the human condition, abnormalities were found in synaptic plasticity and exhibition/inhibition imbalance in neurotransmission. For CCC expression, NKCC1 was unregulated in the hippocampus, leading to elevated intracellular chloride levels, and GABA causes depolarization. This alteration of GABAergic signaling contributes to impaired
long-term potentiation (LTP). In mouse model, NKCC1 is unregulated in hippocampus. The dysregulation of KCC2 and NKCC1 have been observed in schizophrenia in the prefrontal cortex and may impact the exhibition and inhibition switch in patients.
Bipolar disorder Bipolar disorder is a mental health illness that cause extreme mood swing, including emotional high (
mania), and emotional low (depression). Na⁺/K⁺-ATPase generated sodium gradient, which are essential for the function of Na⁺-driven cotransporters, and disturbances in sodium handling have been implicated in bipolar disorder. Patients with bipolar disorder show evidence of impaired Na⁺/K⁺-ATPase activity and altered sodium signaling. ==See also==